Medicare Enrolled

Dr. Walid Mangal, D.O

Ophthalmology · Stuart, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
1050 SE MONTEREY ROAD, SUITE #104, Stuart, FL 34994
7722832020
In practice since 2008 (17 years)
NPI: 1659529055 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mangal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mangal? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mangal

Dr. Walid Mangal is an ophthalmology specialist in Stuart, FL, with 17 years of NPI registration. Based on federal Medicare data, Dr. Mangal performed 45,225 Medicare services across 5,840 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mangal received a total of $8,716 from 20 pharmaceutical and/or device companies across 109 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mangal is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ Top 3% volume in FL $8,716 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Osteopathic Physician 12479 Clear March 31, 2028
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary

Medicare Utilization ↗
45,225
Medicare services
Top 3% in FL for ophthalmology
5,840
Unique beneficiaries
$56
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,660 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
33,360 $29 $76
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
2,446 $66 $192
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
2,215 $31 $85
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
1,225 $94 $238
Aflibercept eye injection (Eylea) 1,010 $687 $1,519
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
982 $28 $81
Fluorescein angiography of retina
A special camera captures images of the blood vessels in the retina and the area between the white part of the eye and the retina after a dye is injected.
906 $207 $516
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
631 $94 $271
Retinal angiography with dye injection
This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body.
610 $108 $241
Retinal and optic nerve function test
A diagnostic test that measures how well the retina and optic nerve are functioning.
462 $92 $270
Ultrasound of eye tissue and structures
A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures.
311 $56 $102
Compounded drug, not otherwise classified
A medication prepared specifically for an individual patient by a pharmacist or physician, tailored to meet unique needs that cannot be fulfilled by commercially available products.
300 $65 $165
Fluorescein angiography of the eye
An imaging test of the front part of the eye using a special camera after a dye is injected to visualize blood flow.
208 $113 $355
Retinal laser destruction of growth
A laser procedure used to destroy abnormal growths in the retina.
132 $413 $1,074
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
120 $82 $237
Extended exam of back of eye with optic nerve drawing
A detailed examination of the posterior section of the eye, including the optic nerve, with documentation through drawing.
94 $11 $33
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
81 $122 $354
Retinal laser treatment for leaking blood vessels
This procedure uses a laser to seal leaking blood vessels in the retina. It is performed to prevent vision loss caused by fluid leakage from damaged retinal vessels.
42 $275 $710
Retinal photocoagulation to prevent detachment
This procedure uses laser light to create small burns on the retina. It is performed to help prevent the retina from detaching from the back of the eye.
36 $199 $1,097
Extended eye exam with retinal drawing
A detailed examination of the back of the eye that includes creating a drawing of the retina.
29 $17 $52
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
25 $48 $130
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$8,716
Total received (2018-2024)
Avg $1,245/year across 7 years
Top 16% in FL for ophthalmology
20
Companies
109
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,716 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$728
2023
$566
2022
$901
2021
$474
2020
$2,097
2019
$3,491
2018
$460

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Carl Zeiss Meditec, Inc.
$3,935
Regeneron Healthcare Solutions, Inc.
$779
Johnson & Johnson Surgical Vision, Inc.
$594
Sun Pharmaceutical Industries Inc.
$564
Kala Pharmaceuticals, Inc.
$525
Astellas Pharma US Inc
$306
Novartis Pharmaceuticals Corporation
$289
Allergan Inc.
$268
Eyevance Pharmaceuticals LLC
$246
Genentech USA, Inc.
$228
Apellis Pharmaceuticals, Inc.
$221
ABBVIE INC.
$167
Allergan, Inc.
$138
Rayner Intraocular Lenses Limited
$125
Harrow Eye, LLC
$105
SUN PHARMACEUTICAL INDUSTRIES INC.
$98
ANI Pharmaceuticals, Inc.
$47
Iridex Corporation
$37
Tarsus Pharmaceuticals, Inc.
$26
Vyera Pharmaceuticals, LLC
$18
Top 3 companies account for 60.9% of total payments
Associated products mentioned in payments ›
BEOVU · BROMSITE · CLARUS · CLARUS 500 Fundus Camera · Cequa · DURYSTA · Daraprim 30 Tablet in 1 Bottle · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · Flarex · IHEEZO · INVELTYS · Izervay · LUMIGAN · Lucentis · OZURDEX · PURIFIED CORTROPHIN GEL · RESTASIS MULTIDOSE · RayOne EMV · Syfovre · Tecnis 1-piece IOL · Tecnis 3-piece IOL · Tecnis IOL · VABYSMO · VUITY · Vabysmo · XDEMVY · XIIDRA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $19 per 100 Medicare services performed
Looking for an ophthalmology specialist in Stuart?
Compare ophthalmologists in the Stuart area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
46
Per 100K population
28.7
County median income
$80,701
Nearest hospital
CLEVELAND CLINIC MARTIN NORTH HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Mangal is a mixed practice specialist, with above-average Medicare volume (top 3% in FL), with low-engagement industry engagement in the top 16% of FL peers, with 17 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Mangal experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Mangal performed 33,360 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mangal receive payments from pharmaceutical companies?
Yes. Dr. Mangal received a total of $8,716 from 20 companies across 109 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mangal's costs compare to other ophthalmologists in Stuart?
Dr. Mangal's average Medicare payment per service is $56. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mangal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →